Advertisement
Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team
philly.com
1 of 0
GlaxoSmithKline P.L.C. and Human Genome Sciences Inc. said today that their experimental drug Benlysta met the goal of a second late-stage study in treating lupus, increasing the odds that the drug will make it to market against a disease that has few new treatments.
Advertisement
This site complies with the HONcode standard for trustworthy health information: verify here.
© 2012 OrganizedWisdom.com, Inc. All rights reserved.
OrganizedWisdom does not provide medical advice, diagnosis or treatment. If you think you
may have a medical emergency, call your doctor or 911 immediately.
As Seen In
